<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">33694180</PMID><DateCompleted><Year>2021</Year><Month>10</Month><Day>22</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>22</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1460-2075</ISSN><JournalIssue CitedMedium="Internet"><Volume>40</Volume><Issue>7</Issue><PubDate><Year>2021</Year><Month>Apr</Month><Day>01</Day></PubDate></JournalIssue><Title>The EMBO journal</Title><ISOAbbreviation>EMBO J</ISOAbbreviation></Journal><ArticleTitle>HDAC6 inhibition restores TDP-43 pathology and axonal transport defects in human motor neurons with TARDBP mutations.</ArticleTitle><Pagination><StartPage>e106177</StartPage><MedlinePgn>e106177</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e106177</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.15252/embj.2020106177</ELocationID><Abstract><AbstractText>TDP-43 is the major component of pathological inclusions in most ALS patients and in up to 50% of patients with frontotemporal dementia (FTD). Heterozygous missense mutations in TARDBP, the gene encoding TDP-43, are one of the common causes of familial ALS. In this study, we investigate TDP-43 protein behavior in induced pluripotent stem cell (iPSC)-derived motor neurons from three ALS patients with different TARDBP mutations, three healthy controls and an isogenic control. TARDPB mutations induce several TDP-43 changes in spinal motor neurons, including cytoplasmic mislocalization and accumulation of insoluble TDP-43, C-terminal fragments, and phospho-TDP-43. By generating iPSC lines with allele-specific tagging of TDP-43, we find that mutant TDP-43 initiates the observed disease phenotypes and has an altered interactome as indicated by mass spectrometry. Our findings also indicate that TDP-43 proteinopathy results in a defect in mitochondrial transport. Lastly, we show that pharmacological inhibition of histone deacetylase 6 (HDAC6) restores the observed TDP-43 pathologies and the axonal mitochondrial motility, suggesting that HDAC6 inhibition may be an interesting therapeutic target for neurodegenerative disorders linked to TDP-43 pathology.</AbstractText><CopyrightInformation>&#xa9; 2021 The Authors. Published under the terms of the CC BY 4.0 license.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Fazal</LastName><ForeName>Raheem</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0001-8833-9997</Identifier><AffiliationInfo><Affiliation>Department of Neurosciences, Experimental Neurology, Leuven Brain Institute (LBI), KU Leuven - University of Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Brain &amp; Disease Research, Laboratory of Neurobiology, VIB, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boeynaems</LastName><ForeName>Steven</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Genetics, Stanford University School of Medicine, Stanford, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Swijsen</LastName><ForeName>Ann</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Neurosciences, Experimental Neurology, Leuven Brain Institute (LBI), KU Leuven - University of Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Brain &amp; Disease Research, Laboratory of Neurobiology, VIB, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Decker</LastName><ForeName>Mathias</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neurosciences, Experimental Neurology, Leuven Brain Institute (LBI), KU Leuven - University of Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Brain &amp; Disease Research, Laboratory of Neurobiology, VIB, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fumagalli</LastName><ForeName>Laura</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Neurosciences, Experimental Neurology, Leuven Brain Institute (LBI), KU Leuven - University of Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Brain &amp; Disease Research, Laboratory of Neurobiology, VIB, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moisse</LastName><ForeName>Matthieu</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neurosciences, Experimental Neurology, Leuven Brain Institute (LBI), KU Leuven - University of Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Brain &amp; Disease Research, Laboratory of Neurobiology, VIB, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vanneste</LastName><ForeName>Joni</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Neurosciences, Experimental Neurology, Leuven Brain Institute (LBI), KU Leuven - University of Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Brain &amp; Disease Research, Laboratory of Neurobiology, VIB, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guo</LastName><ForeName>Wenting</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Neurosciences, Experimental Neurology, Leuven Brain Institute (LBI), KU Leuven - University of Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Brain &amp; Disease Research, Laboratory of Neurobiology, VIB, Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Stem Cell Institute, Department of Development and Regeneration, Stem Cell Biology and Embryology, KU Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boon</LastName><ForeName>Ruben</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-9355-674X</Identifier><AffiliationInfo><Affiliation>Stem Cell Institute, Department of Development and Regeneration, Stem Cell Biology and Embryology, KU Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vercruysse</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Immunology and Transplantation, Laboratory of Virology and Chemotherapy, Rega Institute for Medical Research, KU Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eggermont</LastName><ForeName>Kristel</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Neurosciences, Experimental Neurology, Leuven Brain Institute (LBI), KU Leuven - University of Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Brain &amp; Disease Research, Laboratory of Neurobiology, VIB, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Swinnen</LastName><ForeName>Bart</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Neurosciences, Experimental Neurology, Leuven Brain Institute (LBI), KU Leuven - University of Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Brain &amp; Disease Research, Laboratory of Neurobiology, VIB, Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, University Hospitals Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Beckers</LastName><ForeName>Jimmy</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Neurosciences, Experimental Neurology, Leuven Brain Institute (LBI), KU Leuven - University of Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Brain &amp; Disease Research, Laboratory of Neurobiology, VIB, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pakravan</LastName><ForeName>Donya</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Neurosciences, Experimental Neurology, Leuven Brain Institute (LBI), KU Leuven - University of Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Brain &amp; Disease Research, Laboratory of Neurobiology, VIB, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vandoorne</LastName><ForeName>Tijs</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0003-2431-7785</Identifier><AffiliationInfo><Affiliation>Department of Neurosciences, Experimental Neurology, Leuven Brain Institute (LBI), KU Leuven - University of Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Brain &amp; Disease Research, Laboratory of Neurobiology, VIB, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vanden Berghe</LastName><ForeName>Pieter</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Chronic Diseases, Metabolism and Ageing, Translational Research in GastroIntestinal Disorders, KU Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Verfaillie</LastName><ForeName>Catherine</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Stem Cell Institute, Department of Development and Regeneration, Stem Cell Biology and Embryology, KU Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Van Den Bosch</LastName><ForeName>Ludo</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0003-0104-4067</Identifier><AffiliationInfo><Affiliation>Department of Neurosciences, Experimental Neurology, Leuven Brain Institute (LBI), KU Leuven - University of Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Brain &amp; Disease Research, Laboratory of Neurobiology, VIB, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Van Damme</LastName><ForeName>Philip</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0002-4010-2357</Identifier><AffiliationInfo><Affiliation>Department of Neurosciences, Experimental Neurology, Leuven Brain Institute (LBI), KU Leuven - University of Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Brain &amp; Disease Research, Laboratory of Neurobiology, VIB, Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, University Hospitals Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>03</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>EMBO J</MedlineTA><NlmUniqueID>8208664</NlmUniqueID><ISSNLinking>0261-4189</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004268">DNA-Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D056572">Histone Deacetylase Inhibitors</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000598624">TARDBP protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.5.1.98</RegistryNumber><NameOfSubstance UI="C433811">HDAC6 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.5.1.98</RegistryNumber><NameOfSubstance UI="D000073864">Histone Deacetylase 6</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001370" MajorTopicYN="Y">Axonal Transport</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002478" MajorTopicYN="N">Cells, Cultured</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004268" MajorTopicYN="N">DNA-Binding Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000073864" MajorTopicYN="N">Histone Deacetylase 6</DescriptorName><QualifierName UI="Q000037" MajorTopicYN="N">antagonists &amp; inhibitors</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D056572" MajorTopicYN="N">Histone Deacetylase Inhibitors</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057026" MajorTopicYN="N">Induced Pluripotent Stem Cells</DescriptorName><QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008928" MajorTopicYN="N">Mitochondria</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName><QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020125" MajorTopicYN="N">Mutation, Missense</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">HDAC6</Keyword><Keyword MajorTopicYN="N">TDP-43-ALS</Keyword><Keyword MajorTopicYN="N">axonal transport</Keyword><Keyword MajorTopicYN="N">induced pluripotent stem cells</Keyword><Keyword MajorTopicYN="N">wild-type- and mutant-tagged TDP-43</Keyword></KeywordList><CoiStatement>The authors declare that they have no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>1</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>7</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>2</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>3</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>2</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>3</Month><Day>11</Day><Hour>7</Hour><Minute>14</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33694180</ArticleId><ArticleId IdType="pmc">PMC8013789</ArticleId><ArticleId IdType="doi">10.15252/embj.2020106177</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Abe K, Aoki M, Tsuji S, Itoyama Y, Sobue G, Togo M, Hamada C, Sasaki H, Yabe I, Doi S et al (2017) Open&#x2010;label 24&#x2010;week extension study of edaravone (MCI&#x2010;186) in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Front Degener 18: 55&#x2013;63</Citation></Reference><Reference><Citation>Abo&#x2010;rady M, Kalmbach N, Pal A, Schludi C, Janosch A, Richter T, Freitag P, Bickle M, Kahlert A, Petri S et al (2020) Knocking out C9ORF72 Exacerbates Axonal Trafficking Defects Associated with Hexanucleotide Repeat Expansion and Reduces Levels of Heat Shock Proteins. Stem Cell Reports 14: 390&#x2013;405</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7066330</ArticleId><ArticleId IdType="pubmed">32084385</ArticleId></ArticleIdList></Reference><Reference><Citation>Alami NH, Smith RB, Carrasco MA, Williams LA, Winborn CS, Han SSW, Kiskinis E, Winborn B, Freibaum BD, Kanagaraj A et al (2014) Axonal transport of TDP&#x2010;43 mRNA granules is impaired by ALS&#x2010;causing mutations. Neuron 81: 536&#x2013;543</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3939050</ArticleId><ArticleId IdType="pubmed">24507191</ArticleId></ArticleIdList></Reference><Reference><Citation>Al&#x2010;Chalabi A, Van Den Berg LH, Veldink J (2017) Gene discovery in amyotrophic lateral sclerosis: implications for clinical management. Nat Rev Neurol 13: 96&#x2013;104</Citation><ArticleIdList><ArticleId IdType="pubmed">27982040</ArticleId></ArticleIdList></Reference><Reference><Citation>Arai T, Hasegawa M, Akiyama H, Ikeda K, Nonaka T, Mori H, Mann D, Tsuchiya K, Yoshida M, Hashizume Y et al (2006) TDP&#x2010;43 is a component of ubiquitin&#x2010;positive tau&#x2010;negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem Biophys Res Commun 351: 602&#x2013;611</Citation><ArticleIdList><ArticleId IdType="pubmed">17084815</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnold ES, Ling SC, Huelga SC, Lagier&#x2010;Tourenne C, Polymenidou M, Ditsworth D, Kordasiewicz HB, McAlonis&#x2010;Downes M, Platoshyn O, Parone PA et al (2013) ALS&#x2010;linked TDP&#x2010;43 mutations produce aberrant RNA splicing and adult&#x2010;onset motor neuron disease without aggregation or loss of nuclear TDP&#x2010;43. Proc Natl Acad Sci USA 110: E736&#x2013;E745</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3581922</ArticleId><ArticleId IdType="pubmed">23382207</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayala YM, De Conti L, Avenda&#xf1;o&#x2010;V&#xe1;zquez SE, Dhir A, Romano M, D&#x2019;Ambrogio A, Tollervey J, Ule J, Baralle M, Buratti E et al (2011) TDP&#x2010;43 regulates its mRNA levels through a negative feedback loop. EMBO J 30: 277&#x2013;288</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3025456</ArticleId><ArticleId IdType="pubmed">21131904</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayala YM, Zago P, D&#x2019;Ambrogio A, Xu YF, Petrucelli L, Buratti E, Baralle FE (2008) Structural determinants of the cellular localization and shuttling of TDP&#x2010;43. J Cell Sci 121: 3778&#x2013;3785</Citation><ArticleIdList><ArticleId IdType="pubmed">18957508</ArticleId></ArticleIdList></Reference><Reference><Citation>Baldwin KR, Godena VK, Hewitt VL, Whitworth AJ (2016) Axonal transport defects are a common phenotype in Drosophila models of ALS. Hum Mol Genet 25: 2378&#x2013;2392</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5181624</ArticleId><ArticleId IdType="pubmed">27056981</ArticleId></ArticleIdList></Reference><Reference><Citation>Barmada SJ, Skibinski G, Korb E, Rao EJ, Wu JY, Finkbeiner S (2010) Cytoplasmic mislocalization of TDP&#x2010;43 is toxic to neurons and enhanced by a mutation associated with familial amyotrophic lateral sclerosis. J Neurosci 30: 639&#x2013;649</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2821110</ArticleId><ArticleId IdType="pubmed">20071528</ArticleId></ArticleIdList></Reference><Reference><Citation>Beel S, Herdewyn S, Fazal R, De Decker M, Moisse M, Robberecht W, Van Den Bosch L, Van Damme P (2018) Progranulin reduces insoluble TDP&#x2010;43 levels, slows down axonal degeneration and prolongs survival in mutant TDP&#x2010;43 mice 11 Medical and Health Sciences 1109 Neurosciences. Mol Neurodegener 13: 55</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6192075</ArticleId><ArticleId IdType="pubmed">30326935</ArticleId></ArticleIdList></Reference><Reference><Citation>Bensimon G, Lacomblez L, Meininger V (1994) A controlled trial of riluzole in amyotrophic lateral sclerosis. N Engl J Med 330: 585&#x2013;591</Citation><ArticleIdList><ArticleId IdType="pubmed">8302340</ArticleId></ArticleIdList></Reference><Reference><Citation>Berning BA, Walker AK (2019) The pathobiology of TDP&#x2010;43 C&#x2010;terminal fragments in ALS and FTLD. Front Neurosci 13: 335</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6470282</ArticleId><ArticleId IdType="pubmed">31031584</ArticleId></ArticleIdList></Reference><Reference><Citation>Bilican B, Serio A, Barmada SJ, Nishimura AL, Sullivan GJ, Carrasco M, Phatnani HP, Puddifoot CA, Story D, Fletcher J et al (2012) Mutant induced pluripotent stem cell lines recapitulate aspects of TDP&#x2010;43 proteinopathies and reveal cell&#x2010;specific vulnerability. Proc Natl Acad Sci USA 109: 5803&#x2013;5808</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3326463</ArticleId><ArticleId IdType="pubmed">22451909</ArticleId></ArticleIdList></Reference><Reference><Citation>Borroni B, Bonvicini C, Alberici A, Buratti E, Agosti C, Archetti S, Papetti A, Stuani C, Di Luca M, Gennarelli M et al (2009) Mutation within TARDBP leads to frontotemporal dementia without motor neuron disease. Hum Mutat 30: E974&#x2013;E983</Citation><ArticleIdList><ArticleId IdType="pubmed">19655382</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown RH, Al&#x2010;Chalabi A (2017) Amyotrophic lateral sclerosis. N Engl J Med 377: 162&#x2013;172</Citation><ArticleIdList><ArticleId IdType="pubmed">28700839</ArticleId></ArticleIdList></Reference><Reference><Citation>Buratti E, De Conti L, Stuani C, Romano M, Baralle M, Baralle F (2010) Nuclear factor TDP&#x2010;43 can affect selected microRNA levels. FEBS J 277: 2268&#x2013;2281</Citation><ArticleIdList><ArticleId IdType="pubmed">20423455</ArticleId></ArticleIdList></Reference><Reference><Citation>Burkhardt MF, Martinez FJ, Wright S, Ramos C, Volfson D, Mason M, Garnes J, Dang V, Lievers J, Shoukat&#x2010;Mumtaz U et al (2013) A cellular model for sporadic ALS using patient&#x2010;derived induced pluripotent stem cells. Mol. Cell Neurosci 56: 355&#x2013;364</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4772428</ArticleId><ArticleId IdType="pubmed">23891805</ArticleId></ArticleIdList></Reference><Reference><Citation>Butti Z, Patten SA (2019) RNA Dysregulation in amyotrophic lateral sclerosis. Front Genet 9: 712</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6349704</ArticleId><ArticleId IdType="pubmed">30723494</ArticleId></ArticleIdList></Reference><Reference><Citation>Caroppo P, Camuzat A, Guillot&#x2010;Noel L, Thomas&#x2010;Ant&#xe9;rion C, Couratier P, Wong TH, Teichmann M, Golfier V, Auriacombe S, Belliard S et al (2016) Defining the spectrum of frontotemporal dementias associated with TARDBP mutations. Neurol Genet 2: e80</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4882769</ArticleId><ArticleId IdType="pubmed">27280171</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang XL, Tan MS, Tan L, Yu JT (2016) The Role of TDP&#x2010;43 in Alzheimer&#x2019;s Disease. Mol Neurobiol 53: 3349&#x2013;3359</Citation><ArticleIdList><ArticleId IdType="pubmed">26081142</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen TJ, Lee VMY, Trojanowski JQ (2011) TDP&#x2010;43 functions and pathogenic mechanisms implicated in TDP&#x2010;43 proteinopathies. Trends Mol Med 17: 659&#x2013;667</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3202652</ArticleId><ArticleId IdType="pubmed">21783422</ArticleId></ArticleIdList></Reference><Reference><Citation>Cook C, Gendron TF, Scheffel K, Carlomagno Y, Dunmore J, DeTure M, Petrucelli L (2012) Loss of HDAC6, a novel CHIP substrate, alleviates abnormal tau accumulation. Hum Mol Genet 21: 2936&#x2013;2945</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3373241</ArticleId><ArticleId IdType="pubmed">22492994</ArticleId></ArticleIdList></Reference><Reference><Citation>Cox J, Hein MY, Luber CA, Paron I, Nagaraj N, Mann M (2014) Accurate proteome&#x2010;wide label&#x2010;free quantification by delayed normalization and maximal peptide ratio extraction, termed MaxLFQ. Mol Cell Proteomics 13: 2513&#x2013;2526</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4159666</ArticleId><ArticleId IdType="pubmed">24942700</ArticleId></ArticleIdList></Reference><Reference><Citation>Cox J, Mann M (2008) MaxQuant enables high peptide identification rates, individualized p.p.b.&#x2010;range mass accuracies and proteome&#x2010;wide protein quantification. Nat Biotechnol 26: 1367&#x2013;1372</Citation><ArticleIdList><ArticleId IdType="pubmed">19029910</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;Ydewalle C, Krishnan J, Chiheb DM, Van Damme P, Irobi J, Kozikowski AP, Vanden BP, Timmerman V, Robberecht W, Van Den Bosch L (2011) HDAC6 inhibitors reverse axonal loss in a mouse model of mutant HSPB1&#x2010;induced Charcot&#x2010;Marie&#x2010;Tooth disease. Nat Med 17: 968&#x2013;974</Citation><ArticleIdList><ArticleId IdType="pubmed">21785432</ArticleId></ArticleIdList></Reference><Reference><Citation>Da Cruz S, Cleveland DW (2011) Understanding the role of TDP&#x2010;43 and FUS/TLS in ALS and beyond. Curr Opin Neurobiol 21: 904&#x2013;919</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3228892</ArticleId><ArticleId IdType="pubmed">21813273</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis SA, Gan KA, Dowell JA, Cairns NJ, Gitcho MA (2017) TDP&#x2010;43 expression influences amyloid&#x3b2; plaque deposition and tau aggregation. Neurobiol Dis 103: 154&#x2013;162</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5544914</ArticleId><ArticleId IdType="pubmed">28416393</ArticleId></ArticleIdList></Reference><Reference><Citation>De Conti L, Akinyi MV, Mendoza&#x2010;Maldonado R, Romano M, Baralle M, Buratti E (2015) TDP&#x2010;43 affects splicing profiles and isoform production of genes involved in the apoptotic and mitotic cellular pathways. Nucleic Acids Res 43: 8990&#x2013;9005</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4605304</ArticleId><ArticleId IdType="pubmed">26261209</ArticleId></ArticleIdList></Reference><Reference><Citation>Er&#xe9;ndira Avenda&#xf1;o&#x2010;V&#xe1;zquez S, Dhir A, Bembich S, Buratti E, Proudfoot N, Baralle FE (2012) Autoregulation of TDP&#x2010;43 mRNA levels involves interplay between transcription, splicing, and alternative polyA site selection. Genes Dev 26: 1679&#x2013;1684</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3418585</ArticleId><ArticleId IdType="pubmed">22855830</ArticleId></ArticleIdList></Reference><Reference><Citation>van Es MA (2017) Amyotrophic lateral sclerosis Overview &amp; Practice Essentials. Medscape 377: 1602</Citation></Reference><Reference><Citation>Freibaum BD, Chitta RK, High AA, Taylor JP (2010) Global analysis of TDP&#x2010;43 interacting proteins reveals strong association with RNA splicing and translation machinery. J Proteome Res 9: 1104&#x2013;1120</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2897173</ArticleId><ArticleId IdType="pubmed">20020773</ArticleId></ArticleIdList></Reference><Reference><Citation>French RL, Grese ZR, Aligireddy H, Dhavale DD, Reeb AN, Kedia N, Kotzbauer PT, Bieschke J, Ayala YM (2019) Detection of TAR DNA&#x2010;binding protein 43 (TDP&#x2010;43) oligomers as initial intermediate species during aggregate formation. J Biol Chem 294: 6696&#x2013;6709</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6497947</ArticleId><ArticleId IdType="pubmed">30824544</ArticleId></ArticleIdList></Reference><Reference><Citation>Fumagalli L, Young FL, Boeynaems S, De DM, Mehta A, Swijsen A, Fazal R, Guo W, Moisse M, Beckers J et al (2019) C9orf72&#x2010;derived arginine&#x2010;containing dipeptide repeats associate with axonal transport machinery and impede microtubule&#x2010;based motility. bioRxiv 10.1101/835082 [PREPRINT]</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/835082</ArticleId></ArticleIdList></Reference><Reference><Citation>Gendron TF, Petrucelli L (2011) Rodent models of TDP&#x2010;43 proteinopathy: investigating the mechanisms of TDP&#x2010;43&#x2010;mediated neurodegeneration. J Mol Neurosci 45: 486&#x2013;499</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3207125</ArticleId><ArticleId IdType="pubmed">21811811</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo W, Naujock M, Fumagalli L, Vandoorne T, Baatsen P, Boon R, Ordov&#xe1;s L, Patel A, Welters M, Vanwelden T et al (2017) HDAC6 inhibition reverses axonal transport defects in motor neurons derived from FUS&#x2010;ALS patients. Nat Commun 8: 861</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5636840</ArticleId><ArticleId IdType="pubmed">29021520</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo W, Stoklund Dittlau K, Van Den Bosch L (2019) Axonal transport defects and neurodegeneration: Molecular mechanisms and therapeutic implications. Semin Cell Dev Biol 99: 133&#x2013;150</Citation><ArticleIdList><ArticleId IdType="pubmed">31542222</ArticleId></ArticleIdList></Reference><Reference><Citation>Hall CE, Yao Z, Choi M, Tyzack GE, Serio A, Luisier R, Harley J, Preza E, Arber C, Crisp SJ et al (2017) Progressive motor neuron pathology and the role of astrocytes in a human stem cell model of VCP&#x2010;related ALS. Cell Rep 19: 1739&#x2013;1749</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5464993</ArticleId><ArticleId IdType="pubmed">28564594</ArticleId></ArticleIdList></Reference><Reference><Citation>Hardiman O, Al&#x2010;chalabi A, Chio A, Corr EM, Robberecht W, Shaw PJ, Simmons Z (2017) Amyotrophic lateral sclerosis. Nat. Rev. Dis. Prim. 3: 17071</Citation><ArticleIdList><ArticleId IdType="pubmed">28980624</ArticleId></ArticleIdList></Reference><Reference><Citation>Hasegawa M, Arai T, Nonaka T, Kametani F, Yoshida M, Hashizume Y, Beach TG, Buratti E, Baralle F, Morita M et al (2008) Phosphorylated TDP&#x2010;43 in frontotemporal lobar degeneration and ALS. Ann Neurol 64: 60&#x2013;70</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2674108</ArticleId><ArticleId IdType="pubmed">18546284</ArticleId></ArticleIdList></Reference><Reference><Citation>Hebron ML, Lonskaya I, Sharpe K, Weerasinghe PPK, Algarzae NK, Shekoyan AR, Moussa CEH (2013) Parkin ubiquitinates tar&#x2010;DNA binding protein&#x2010;43 (TDP&#x2010;43) and promotes its cytosolic accumulation via interaction with histone deacetylase 6 (HDAC6). J Biol Chem 288: 4103&#x2013;4115</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3567661</ArticleId><ArticleId IdType="pubmed">23258539</ArticleId></ArticleIdList></Reference><Reference><Citation>Highley JR, Kirby J, Jansweijer JA, Webb PS, Hewamadduma CA, Heath PR, Higginbottom A, Raman R, Ferraiuolo L, Cooper&#x2010;Knock J et al (2014) Loss of nuclear TDP&#x2010;43 in amyotrophic lateral sclerosis (ALS) causes altered expression of splicing machinery and widespread dysregulation of RNA splicing in motor neurones. Neuropathol Appl Neurobiol 40: 670&#x2013;685</Citation><ArticleIdList><ArticleId IdType="pubmed">24750229</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang DW, Sherman BT, Lempicki RA (2009) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4: 44&#x2013;57</Citation><ArticleIdList><ArticleId IdType="pubmed">19131956</ArticleId></ArticleIdList></Reference><Reference><Citation>Hubbert C, Guardiola A, Shao R, Kawaguchi Y, Ito A, Nixon A, Yoshida M, Wang XF, Yao TP (2002) HDAC6 is a microtubule&#x2010;associated deacetylase. Nature 417: 455&#x2013;458</Citation><ArticleIdList><ArticleId IdType="pubmed">12024216</ArticleId></ArticleIdList></Reference><Reference><Citation>Igaz LM, Kwong LK, Xu Y, Truax AC, Uryu K, Neumann M, Clark CM, Elman LB, Miller BL, Grossman M et al (2008) Enrichment of C&#x2010;terminal fragments in TAR DNA&#x2010;binding protein&#x2010;43 cytoplasmic inclusions in brain but not in spinal cord of frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Am J Pathol 173: 182&#x2013;194</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2438296</ArticleId><ArticleId IdType="pubmed">18535185</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson BS, Snead D, Lee JJ, McCaffery JM, Shorter J, Gitler AD (2009) TDP&#x2010;43 is intrinsically aggregation&#x2010;prone, and amyotrophic lateral sclerosis&#x2010;linked mutations accelerate aggregation and increase toxicity. J Biol Chem 284: 20329&#x2013;20339</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2740458</ArticleId><ArticleId IdType="pubmed">19465477</ArticleId></ArticleIdList></Reference><Reference><Citation>Josephs KA, Whitwell JL, Weigand SD, Murray ME, Tosakulwong N, Liesinger AM, Petrucelli L, Senjem ML, Knopman DS, Boeve BF et al (2014) TDP&#x2010;43 is a key player in the clinical features associated with Alzheimer&#x2019;s disease. Acta Neuropathol 127: 811&#x2013;824</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4172544</ArticleId><ArticleId IdType="pubmed">24659241</ArticleId></ArticleIdList></Reference><Reference><Citation>Kabashi E, Valdmanis PN, Dion P, Spiegelman D, McConkey BJ, Vande VC, Bouchard JP, Lacomblez L, Pochigaeva K, Salachas F et al (2008) TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis. Nat Genet 40: 572&#x2013;574</Citation><ArticleIdList><ArticleId IdType="pubmed">18372902</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiskinis E, Sandoe J, Williams LA, Boulting GL, Moccia R, Wainger BJ, Han S, Peng T, Thams S, Mikkilineni S et al (2014) Pathways disrupted in human ALS motor neurons identified through genetic correction of mutant SOD1. Cell Stem Cell 14: 781&#x2013;795</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4653065</ArticleId><ArticleId IdType="pubmed">24704492</ArticleId></ArticleIdList></Reference><Reference><Citation>Klim JR, Williams LA, Limone F, Guerra San Juan I, Davis&#x2010;Dusenbery BN, Mordes DA, Burberry A, Steinbaugh MJ, Gamage KK, Kirchner R et al (2019) ALS&#x2010;implicated protein TDP&#x2010;43 sustains levels of STMN2, a mediator of motor neuron growth and repair. Nat Neurosci 22: 167&#x2013;179</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7153761</ArticleId><ArticleId IdType="pubmed">30643292</ArticleId></ArticleIdList></Reference><Reference><Citation>Kreiter N, Pal A, Lojewski X, Corcia P, Naujock M, Reinhardt P, Sterneckert J, Petri S, Wegner F, Storch A et al (2018) Age&#x2010;dependent neurodegeneration and organelle transport deficiencies in mutant TDP43 patient&#x2010;derived neurons are independent of TDP43 aggregation. Neurobiol Dis 115: 167&#x2013;181</Citation><ArticleIdList><ArticleId IdType="pubmed">29630989</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar V, Wahiduzzaman PA, Tomar AK, Srivastava A, Kundu B, Lynn AM, Imtaiyaz Hassan M (2019) Exploring the aggregation&#x2010;prone regions from structural domains of human TDP&#x2010;43. Biochim Biophys Acta Proteins Proteom 1867: 286&#x2013;296</Citation><ArticleIdList><ArticleId IdType="pubmed">30315897</ArticleId></ArticleIdList></Reference><Reference><Citation>Lemmens R, Race V, Hersmus N, Matthijs G, Van Den Bosch L, Van Damme P, Dubois B, Boonen S, Goris A, Robberecht W (2009) TDP&#x2010;43 M311V mutation in familial amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 80: 354&#x2013;355</Citation><ArticleIdList><ArticleId IdType="pubmed">19228676</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y, Ray P, Rao EJ, Shi C, Guo W, Chen X, Woodruff EA, Fushimi K, Wu JY (2010) A Drosophila model for TDP&#x2010;43 proteinopathy. Proc Natl Acad Sci USA 107: 3169&#x2013;3174</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2840283</ArticleId><ArticleId IdType="pubmed">20133767</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin G, Mao D, Bellen HJ (2017) Amyotrophic lateral sclerosis pathogenesis converges on defects in protein homeostasis associated with TDP&#x2010;43 mislocalization and proteasome&#x2010;mediated degradation overload. Curr Top Dev Biol 121: 111&#x2013;171</Citation><ArticleIdList><ArticleId IdType="pubmed">28057298</ArticleId></ArticleIdList></Reference><Reference><Citation>Mancuso R, Van Den Daele J, Fattorelli N, Wolfs L, Balusu S, Burton O, Liston A, Sierksma A, Fourne Y, Poovathingal S et al (2019) Stem&#x2010;cell&#x2010;derived human microglia transplanted in mouse brain to study human disease. Nat Neurosci 22: 2111&#x2013;2116</Citation><ArticleIdList><ArticleId IdType="pubmed">31659342</ArticleId></ArticleIdList></Reference><Reference><Citation>Masrori P, Van Damme P (2020) Amyotrophic lateral sclerosis: a clinical review. Eur J Neurol 27: 1918&#x2013;1929</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7540334</ArticleId><ArticleId IdType="pubmed">32526057</ArticleId></ArticleIdList></Reference><Reference><Citation>Maury Y, C&#xf4;me J, Piskorowski RA, Salah&#x2010;Mohellibi N, Chevaleyre V, Peschanski M, Martinat C, Nedelec S (2015) Combinatorial analysis of developmental cues efficiently converts human pluripotent stem cells into multiple neuronal subtypes. Nat Biotechnol 33: 89&#x2013;96</Citation><ArticleIdList><ArticleId IdType="pubmed">25383599</ArticleId></ArticleIdList></Reference><Reference><Citation>Melamed Z, L&#xf3;pez&#x2010;Erauskin J, Baughn MW, Zhang O, Drenner K, Sun Y, Freyermuth F, McMahon MA, Beccari MS, Artates JW et al (2019) Premature polyadenylation&#x2010;mediated loss of stathmin&#x2010;2 is a hallmark of TDP&#x2010;43&#x2010;dependent neurodegeneration. Nat Neurosci 22: 180&#x2013;190</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6348009</ArticleId><ArticleId IdType="pubmed">30643298</ArticleId></ArticleIdList></Reference><Reference><Citation>Neary D, Snowden J, Mann D (2005) Neary2005_FTD. Lancet Neurol 4: 771&#x2013;780</Citation><ArticleIdList><ArticleId IdType="pubmed">16239184</ArticleId></ArticleIdList></Reference><Reference><Citation>Nelson PT, Dickson DW, Trojanowski JQ, Jack CR, Boyle PA, Arfanakis K, Rademakers R, Alafuzoff I, Attems J, Brayne C et al (2019) Limbic&#x2010;predominant age&#x2010;related TDP&#x2010;43 encephalopathy (LATE): Consensus working group report. Brain 142: 1503&#x2013;1527</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6536849</ArticleId><ArticleId IdType="pubmed">31039256</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M, Kwong LK, Truax AC, Vanmassenhove B, Kretzschmar HA, Van Deerlin VM, Clark CM, Grossman M, Miller BL, Trojanowski JQ et al (2007) TDP&#x2010;43&#x2010;positive white matter pathology in frontotemporal lobar degeneration with ubiquitin&#x2010;positive inclusions. J Neuropathol Exp Neurol 142: 1503&#x2013;1527</Citation><ArticleIdList><ArticleId IdType="pubmed">17356379</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC, Chou TT, Bruce J, Schuck T, Grossman M, Clark CM et al (2006) Ubiquitinated TDP&#x2010;43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 314: 130&#x2013;133</Citation><ArticleIdList><ArticleId IdType="pubmed">17023659</ArticleId></ArticleIdList></Reference><Reference><Citation>Ordov&#xe1;s L, Boon R, Pistoni M, Chen Y, Wolfs E, Guo W, Sambathkumar R, Bobis&#x2010;Wozowicz S, Helsen N, Vanhove J et al (2015) Efficient recombinase&#x2010;mediated cassette exchange in hPSCs to study the hepatocyte lineage reveals AAVS1 locus&#x2010;mediated transgene inhibition. Stem Cell Reports 5: 918&#x2013;931</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4649136</ArticleId><ArticleId IdType="pubmed">26455413</ArticleId></ArticleIdList></Reference><Reference><Citation>Pandey UB, Nie Z, Batlevi Y, McCray BA, Ritson GP, Nedelsky NB, Schwartz SL, Diprospero NA, Knight MA, Schuldiner O et al (2007) HDAC6 rescues neurodegeneration and provides an essential link between autophagy and the UPS. Nature 447: 859&#x2013;863</Citation><ArticleIdList><ArticleId IdType="pubmed">17568747</ArticleId></ArticleIdList></Reference><Reference><Citation>Patro R, Duggal G, Love MI, Irizarry RA, Kingsford C (2017) Salmon provides fast and bias&#x2010;aware quantification of transcript expression. Nat Methods 14: 417&#x2013;419</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5600148</ArticleId><ArticleId IdType="pubmed">28263959</ArticleId></ArticleIdList></Reference><Reference><Citation>Polymenidou M, Lagier&#x2010;Tourenne C, Hutt KR, Huelga SC, Moran J, Liang TY, Ling SC, Sun E, Wancewicz E, Mazur C et al (2011) Long pre&#x2010;mRNA depletion and RNA missplicing contribute to neuronal vulnerability from loss of TDP&#x2010;43. Nat Neurosci 14: 459&#x2013;468</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3094729</ArticleId><ArticleId IdType="pubmed">21358643</ArticleId></ArticleIdList></Reference><Reference><Citation>Prior R, Van Helleputte L, Benoy V, Van Den Bosch L (2017) Defective axonal transport: a common pathological mechanism in inherited and acquired peripheral neuropathies. Neurobiol Dis 105: 300&#x2013;320</Citation><ArticleIdList><ArticleId IdType="pubmed">28238949</ArticleId></ArticleIdList></Reference><Reference><Citation>Rossaert E, Van Den Bosch L (2020) HDAC6 inhibitors: Translating genetic and molecular insights into a therapy for axonal CMT. Brain Res 1733: 146692</Citation><ArticleIdList><ArticleId IdType="pubmed">32006555</ArticleId></ArticleIdList></Reference><Reference><Citation>Seminary ER, Sison SL, Ebert AD (2018) Modeling protein aggregation and the heat shock response in ALS iPSC&#x2010;derived motor neurons. Front Neurosci 12: 86</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5826239</ArticleId><ArticleId IdType="pubmed">29515358</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen S, Benoy V, Bergman JA, Kalin JH, Frojuello M, Vistoli G, Haeck W, Van Den Bosch L, Kozikowski AP (2016) Bicyclic&#x2010;capped histone deacetylase 6 inhibitors with improved activity in a model of axonal charcot&#x2010;marie&#x2010;tooth disease. ACS Chem Neurosci 7: 240&#x2013;258</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4775085</ArticleId><ArticleId IdType="pubmed">26599234</ArticleId></ArticleIdList></Reference><Reference><Citation>Sim&#xf5;es&#x2010;Pires C, Zwick V, Nurisso A, Schenker E, Carrupt PA, Cuendet M (2013) HDAC6 as a target for neurodegenerative diseases: What makes it different from the other HDACs? Mol Neurodegener 8: 7</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3615964</ArticleId><ArticleId IdType="pubmed">23356410</ArticleId></ArticleIdList></Reference><Reference><Citation>Sleigh JN, Tosolini AP, Gordon D, Devoy A, Fratta P, Fisher EMC, Talbot K, Schiavo G (2020) Mice carrying ALS mutant TDP&#x2010;43, but Not mutant FUS, display in vivo defects in axonal transport of signaling endosomes. Cell Rep 30: 3655&#x2013;3662</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7090381</ArticleId><ArticleId IdType="pubmed">32187538</ArticleId></ArticleIdList></Reference><Reference><Citation>Soneson C, Love MI, Robinson MD (2016) Differential analyses for RNA&#x2010;seq: transcript&#x2010;level inferences. F1000Res 4: 1521</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4712774</ArticleId><ArticleId IdType="pubmed">26925227</ArticleId></ArticleIdList></Reference><Reference><Citation>Sreedharan J, Blair IP, Tripathi VB, Hu X, Vance C, Rogelj B, Ackerley S, Durnall JC, Williams KL, Buratti E et al (2008) TDP&#x2010;43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science 319: 1668&#x2013;1672</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7116650</ArticleId><ArticleId IdType="pubmed">18309045</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun X, Song J, Huang H, Chen H, Qian K (2018) Modeling hallmark pathology using motor neurons derived from the family and sporadic amyotrophic lateral sclerosis patient&#x2010;specific iPS cells. Stem Cell Res Ther 9: 315</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6238404</ArticleId><ArticleId IdType="pubmed">30442180</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan Q, Yalamanchili HK, Park J, De Maio A, Lu HC, Wan YW, White JJ, Bondar VV, Sayegh LS, Liu X et al (2016) Extensive cryptic splicing upon loss of RBM17 and TDP43 in neurodegeneration models. Hum Mol Genet 25: 5083&#x2013;5093</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5968355</ArticleId><ArticleId IdType="pubmed">28007900</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsuiji H, Kataoka A, Yamanaka K (2011) Regulation of spliceosome by ALS&#x2010;causative gene TDP&#x2010;43. Neurosci Res 71: e102</Citation></Reference><Reference><Citation>Tyanova S, Temu T, Sinitcyn P, Carlson A, Hein MY, Geiger T, Mann M, Cox J (2016) The Perseus computational platform for comprehensive analysis of (prote)omics data. Nat Methods 13: 731&#x2013;740</Citation><ArticleIdList><ArticleId IdType="pubmed">27348712</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Deerlin VM, Leverenz JB, Bekris LM, Bird TD, Yuan W, Elman LB, Clay D, Wood EMC, Chen&#x2010;Plotkin AS, Martinez&#x2010;Lage M et al (2008) TARDBP mutations in amyotrophic lateral sclerosis with TDP&#x2010;43 neuropathology: a genetic and histopathological analysis. Lancet Neurol 7: 409&#x2013;416</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3546119</ArticleId><ArticleId IdType="pubmed">18396105</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Helleputte L, Kater M, Cook DP, Eykens C, Rossaert E, Haeck W, Jaspers T, Geens N, Vanden Berghe P, Gysemans C et al (2018) Inhibition of histone deacetylase 6 (HDAC6) protects against vincristine&#x2010;induced peripheral neuropathies and inhibits tumor growth. Neurobiol Dis 111: 59&#x2013;69</Citation><ArticleIdList><ArticleId IdType="pubmed">29197621</ArticleId></ArticleIdList></Reference><Reference><Citation>Vandoorne T, Veys K, Guo W, Sicart A, Vints K, Swijsen A, Moisse M, Eelen G, Gounko NV, Fumagalli L et al (2019) Differentiation but not ALS mutations in FUS rewires motor neuron metabolism. Nat Commun 10: 4147</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6742665</ArticleId><ArticleId IdType="pubmed">31515480</ArticleId></ArticleIdList></Reference><Reference><Citation>Wegorzewska I, Baloh RH (2011) TDP&#x2010;43&#x2010;based animal models of neurodegeneration: new insights into ALS pathology and pathophysiology. Neurodegener Dis 8: 262&#x2013;274</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3214943</ArticleId><ArticleId IdType="pubmed">21124004</ArticleId></ArticleIdList></Reference><Reference><Citation>Weskamp K, Barmada SJ (2018) TDP43 and RNA instability in amyotrophic lateral sclerosis. Brain Res 1693: 67&#x2013;74</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5997512</ArticleId><ArticleId IdType="pubmed">29395044</ArticleId></ArticleIdList></Reference><Reference><Citation>White MA, Kim E, Duffy A, Adalbert R, Phillips BU, Peters OM, Stephenson J, Yang S, Massenzio F, Lin Z et al (2018) TDP&#x2010;43 gains function due to perturbed autoregulation in a Tardbp knock&#x2010;in mouse model of ALS&#x2010;FTD. Nat Neurosci 21: 552&#x2013;563</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5884423</ArticleId><ArticleId IdType="pubmed">29556029</ArticleId></ArticleIdList></Reference><Reference><Citation>Winton MJ, Igaz LM, Wong MM, Kwong LK, Trojanowski JQ, Lee VMY (2008) Disturbance of nuclear and cytoplasmic TAR DNA&#x2010;binding protein (TDP&#x2010;43) induces disease&#x2010;like redistribution, sequestration, and aggregate formation. J Biol Chem 283: 13302&#x2013;13309</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2442318</ArticleId><ArticleId IdType="pubmed">18305110</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan J (2014) Interplay between HDAC6 and its interacting partners: essential roles in the aggresome&#x2010;autophagy pathway and neurodegenerative diseases. DNA Cell Biol 33: 567&#x2013;580</Citation><ArticleIdList><ArticleId IdType="pubmed">24932665</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>